Contact

Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Translational & Preclinical Development

Chromium X: the Most Flexible Way to Single Cell

Single cell analysis has been a revolutionary breakthrough in biology. Understanding cellular diversity has enabled significant insights into intracellular mechanisms and their applications to health and disease. But for many researchers, single cell has been out of reach due to technical, cost-per-cell, and scalability challenges.
Read More
Translational & Preclinical Development

10x Genomics: Inside Visium Spatial Capture Technology

Visium Spatial Gene Expression incorporates whole transcriptome analysis for intact tissues sections with morphological context. Bringing these complementary methods together offers a previously inaccessible view of tissue biology.
Read More
Translational & Preclinical Development

Synexa Life Sciences: ProtoTrials®

Enhancing human ex vivo translational outcomes.
Read More
Translational & Preclinical Development

Handbook for Stem Cell Research

This whitepaper by Sino Biological discusses the different types of stem cells based on their origin and potential, as well as the factors that direct their differentiation toward specific lineages or cell types.
Read More
Translational & Preclinical Development

iBio Reports Antibody Hat-Trick in its In Vivo IO Programs

Significant progress in iBio's in vivo preclinical programs with positive data from three antibody candidates: anti-EGFRvIII, CCR8, and TROP-2 x CD3.
Read More
Translational & Preclinical Development

Using Mouse Models for Preclinical Immuno Oncology

Unveiling advancements in preclinical immuno-oncology: Exploring humanized mouse models and human knock-in mice for targeted cancer therapies.
Read More
Translational & Preclinical Development

Transformative Partnership: Ozette Technologies and Umoja Biopharma Join Forces for Preclinical Studies

The collaboration aims to expand access to immunotherapies and advance the field of CAR T cell therapy.
Read More
Translational & Preclinical Development

Canopy Biosciences: Using the ROSALIND Platform to Accelerate Single-Cell Data Analysis

Single-Cell RNA-Sequencing CRO Service.
Read More
Translational & Preclinical Development

ChemPartner: Tailored Drug Discovery & Development

ChemPartner has the capabilities and expertise to support the end to end drug discovery process across multiple modalities (illustrated below with the small molecule flow scheme). We support the process with expertise and resources at every stage in a fully managed and integrated manner.
Read More
Translational & Preclinical Development

ChemPartner: Nuclear Hormone Receptor Screening

Overview of Capabilities.
Read More
Translational & Preclinical Development

ChemPartner: Oncology Pharmacology

Read More
Translational & Preclinical Development

ChemPartner: Protein Sciences

Read More
Translational & Preclinical Development

ChemPartner: Cancer Cell Line Panel Screening

Leading Cell-Based Assay Service
Read More
Translational & Preclinical Development

ChemPartner: Cell Biology

Overview
Read More
Translational & Preclinical Development

Functional Evaluation of Unique Anti-PDL1 Antibodies Generated through Single Plasma B Cell Cloning on the Beacon® Platform Versus a Standard Hybridoma Approach

Read More
Translational & Preclinical Development

Crown Bioscience: Discover the Infinite Power of Partnership

We are Crown Bioscience and this is where Innovation and Quality Transforms Scientific Discovery
Read More
Translational & Preclinical Development

Evaxion Biotech Announce New Source of Immunotherapeutic Targets via AI Platform

ERVs have been strongly associated with overall survival in cancer patients. Evaxion hopes they can act as therapeutic targets for non-responsive immunotherapy patients.
Read More
Translational & Preclinical Development

Sensei Bio Presents Preclinical Data for Novel Antibody Therapeutic for Solid Tumours

Immuno-oncology company Sensei Bio gave a presentation which outlined convincing preclinical data for their novel antibody therapeutic.
Read More
Translational & Preclinical Development

AI-Guided Personalised Cancer Vaccine Designated Fast Track by FDA

Evaxion Biotech uses AI to personalise cancer vaccines for patients’ specific tumours.
Read More
Translational & Preclinical Development

Teon Tx and MSD Partner in Oral IO Clinical Trial

Teon Tx and MSD will partner to study a combination of a new immune-modifier and existing anti-PD-1 immune checkpoint inhibitor.
Read More
Translational & Preclinical Development

New Funding Given to Network of Experimental Cancer Medicine Centres

The ECMC network will enter new partnerships to increase the availability of clinical trials for cancer patients.
Read More
Translational & Preclinical Development

Approaches to Combinational Immunotherapies: From Clinic to Approval

Our panel discussing combination therapeutics addresses challenges, modelling, and the importance of biomarkers.
Read More
Translational & Preclinical Development

Delivering Immuno-Oncology Therapies for Solid Tumours

The panel at Immuno UK 2022 discuss the unique challenges that come with delivering immunotherapies to solid malignancies.
Read More
Translational & Preclinical Development

Sample Storage - MLM Medical Services

Read More
Translational & Preclinical Development

Western Blot Services - Champions Oncology

Read More
Translational & Preclinical Development

Histology and Immunohistochemistry Services - Champions Oncology

Read More
Translational & Preclinical Development

Comprehensive T Cell Checkpoint Panel - Champions Oncology

Read More
Translational & Preclinical Development

Validated Human Complex Immunophenotyping Panel II - Champions Oncology

Read More
Translational & Preclinical Development

Complex Immunophenotyping Panel I - Champions Oncology

Read More
Translational & Preclinical Development

Autologous Tumor Infiltrating Lymphocyte (TIL) Platform - Champions Oncology

Read More
Translational & Preclinical Development

PhenoSeek AML Flow Cytometry Pane - Champions Oncology

Read More
Translational & Preclinical Development

NeoScreen: In Vitro Analysis of Potential Cancer Neo-Epitopes - Immunitrack

Read More
Translational & Preclinical Development

Immunohistochemistry Services - Indivumed

Read More
Translational & Preclinical Development

Safety Lab Services - MLM Medical Labs

Read More
Translational & Preclinical Development

Histology Services - MLM Medical Labs

Read More
Translational & Preclinical Development

Animal Health - MLM Medical Labs

Read More
Translational & Preclinical Development

Virology Studies with Maestro Z - Axion Biosystems

Read More
Translational & Preclinical Development

Biognosys Research Services

Read More
Translational & Preclinical Development

Developing Tumor Spheroid Protocol - CellLink

Read More
Translational & Preclinical Development

Anti-Idiotypic Antibody Production - Rockland

pre
Read More
Translational & Preclinical Development

Rockland Custom Services

Read More
Translational & Preclinical Development

Host Cell Protein & Bioprocessing Reagent Development - Rockland

Read More
Translational & Preclinical Development

Preclinical Strategies for Combination Immunotherapies

Oncology is almost always oriented towards simultaneous treatment options. We explore why as well as the approach’s unique challenges.
Read More
Translational & Preclinical Development

AAV Gene Therapy and CAR T Therapies: Immunogenicity and Immunoassay Development

Dr. Vibha Jawa, Executive Director, Nonclinical Disposition and Bioanalysis at BMS
Read More
Translational & Preclinical Development

Investigating the Core Tenet of Immunotherapy: MHC-I Peptide-Receptor Complexes

Axel Ducret, a Roche Senior Principal Scientist, takes us through his work on one of the most important cellular mechanisms in immunotherapy.
Read More
Translational & Preclinical Development

The Future of CAR T for Solid Tumours: Antigen Discovery, Persistence, and Fitness

CAR T, the rockstar therapy of immuno-oncology, finds its next big challenge in translating research for use in solid tumours.
Read More
Translational & Preclinical Development

Developing Novel Theranostic Approaches for the Development of Oncolytic Viruses

Single-cell, real-time analysis of oncolytic viruses’ efficacy, and replication in living cancer cells.
Read More
Translational & Preclinical Development

Better IO Clinical Trials with ImmunoPET Imaging

Ian A Wilson of ImaginAb delivers the presentation ‘The Value of In Vivo Imaging on the Clinical Development of IO Drugs’ at Oxford Global’s discussion group.
Read More
Translational & Preclinical Development

Search and Destroy: Engineering T-Cells to Find and Kill Cancer

Oxford Global’s Immuno Week showcased new ways of reprogramming the immune system to treat malignancy with TCR-T.
Read More
Translational & Preclinical Development

Multi-Specific Protein Modalities For Solid Tumours

An interview with Rajika Perera, Chief Executive Officer, Poseidon Laboratory
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno